Skip to content

Author

Lina Wu

We have 3 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Oxygen-Amplified Carrier-Free Nanomedicine Integrating Ferroptosis/Photodynamic Therapy and COX-2/PGE2 Blockade for Robust Antitumor Immunity Against Glioma.

An oxygen‑amplified carrier‑free nanomedicine (IHC NPs) through hydrophobic self‑assembly of IR-820, hemin, and celecoxib is developed that provides a promising oxygen‑amplified carrier‑free nanomedicine for robust glioma immunotherapy.

Yin-Xing Huang, Bin Liu, Zhen-Hong Pan et al. · 0 citations
Open access Aug 2026

Imaging-guided COX-2 inhibition synergizes with photodynamic immunogenic cell death to potentiate checkpoint blockade in colon cancer

The findings elucidate the mechanism underlying the co-administration of VER and CXB, demonstrate the advantages of albumin as a superior drug carrier, and establish the combination of VC@HSA with ICB as a promising therapeutic strategy for colon cancer.

Lina Wu, Xi-Jun Chen, Jiao-Ling He et al. · 0 citations
Aug 2026

Quaternary ammonium-functionalized carbon quantum dots with low drug resistance inhibit biofilm formation and accelerate infected wound healing.

Findings establish quaternized tartaric acid-based carbon quantum dots as a robust, biocompatible nanoplatform that simultaneously combats drug-resistant bacteria and mitigates resistance evolution, representing a meaningful step toward developing next-generation antimicrobial strategies to address the global crisis of...

Lina Wu, Xian-Quan Feng, Yaoran Gao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.